Mechanistically, GAS5 could bind E2F4, recruit it to the EZH2 promoter, and repress EZH2 expression, leading to enhanced apoptosis and reduced viability of bladder cancer cells 136 (Figure 2D). Here, EZH2 is linked to urinary bladder cancer.